Paclitaxel synergizes with exposure time adjusted CD22-targeting immunotoxins against B-cell malignancies

por Müller, Fabian, Stookey, Stephanie, Cunningham, Tyler, Pastan, Ira
Publicado 2017

eIF4A inhibition: ready for primetime?

por Cunningham, Tyler A., Chapman, Eli, Schatz, Jonathan H.
Publicado 2018

Domain II of Pseudomonas Exotoxin Is Critical for Efficacy of Bolus Doses in a Xenograft Model of Acute Lymphoblastic Leukemia

por Müller, Fabian, Cunningham, Tyler, Beers, Richard, Bera, Tapan K., Wayne, Alan S., Pastan, Ira
Publicado 2018

MATRIX platform to analyze translation machinery remodeling in glioblastoma cells

por Ho, J.J. David, Cunningham, Tyler A., Krieger, Jonathan R., Schatz, Jonathan H., Lee, Stephen
Publicado 2022

Molecular Dynamics Simulations Identify Tractable Lead-like Phenyl-Piperazine Scaffolds as eIF4A1 ATP-competitive Inhibitors

por Essegian, Derek J., Cunningham, Tyler A., Zerio, Christopher J., Chapman, Eli, Schatz, Jonathan, Schürer, Stephan C.
Publicado 2021

Proteomics reveal cap-dependent translation inhibitors remodel the translation machinery and translatome

por Ho, J.J. David, Cunningham, Tyler A., Manara, Paola, Coughlin, Caroline A., Arumov, Artavazd, Roberts, Evan R., Osteen, Ashanti, Kumar, Preet, Bilbao, Daniel, Krieger, Jonathan R., Lee, Stephen, Schatz, Jonathan H.
Publicado 2021